ArticlePharmaceuticals (Basel, Switzerland)2026

Evaluation of Pyrazolone-Based Hydrazones as Potential Therapeutic Agents Against Glioblastoma.

Giorgio Cameli et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.